Suzhou Ribo Life Science

Suzhou Ribo Life Science

Suzhou Ribo Life Science

Suzhou Ribo Life Science develops nucleic acid drugs and related products based on the RNA interference technology.
Founded
2007
Raised
$60M
Follow us
Latest funding
$60,000,000
Venture capital (Series C) - 2020
Hillhouse Capital Group SAIC Capital China State-Owned Capital Venture Investment Fund +1
Team Size
1–10
Employees
Location
Headquarters
$60,000,000 Venture capital (Series C)
DealStreetAsia

China Digest: Ribo Life Science nets $60m; QST raises $49m